網膜診療クローズアップ　改訂第2版

出版社： メジカルビュー社
著者：
発行日： 2018-03-20
分野： 臨床医学：外科  >  眼科学
ISBN： 9784758316347
電子書籍版： 2018-03-20 （第2版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

12,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

12,100 円(税込)

購入する

商品紹介

網膜疾患に携わる医療従事者に向け，基本知識から最新の診療技術にいたるまで網羅的に解説し好評をいただいた初版上梓から5年が経過。本書改訂第2版では，進歩が目覚しかった眼底画像検査，ことに超広角眼底検査所見，OCTアンギオグラフィなど最新画像写真を追加。また，新たな疾患項目，新しい疾患概念をプラスし，新たなエビデンスを基に最新の治療方針を掲載。患者さんの診療により役立つ内容に刷新している。

目次

  • I　網膜疾患診療の基本
    　診断のポイント
    　検査の進め方
    　
    II　黄斑疾患
    　加齢黄斑変性
    　　　前駆病変
    　　　滲出型加齢黄斑変性／概説
    　　　滲出型加齢黄斑変性／典型加齢黄斑変性
    　　　滲出型加齢黄斑変性／ポリープ状脈絡膜血管症
    　　　滲出型加齢黄斑変性／網膜血管腫状増殖
    　　　滲出型加齢黄斑変性／網膜色素上皮剝離
    　　　滲出型加齢黄斑変性／特殊な病態　黄斑下血腫
    　　　萎縮型加齢黄斑変性
    　中心性漿液性脈絡網膜症
    　pachychoroid spectrum diseases
    　強度近視
    　　　強度近視眼底
    　　　近視性新生血管黄斑症
    　　　近視性黄斑牽引症
    　　　近視性黄斑円孔
    　　　dome-shaped macula
    　傾斜乳頭症候群
    　特発性新生血管黄斑症
    　網膜色素線条
    　黄斑部毛細血管拡張症
    　　　aneurysmal telangiectasia (Group 1)
    　　　parafoveal telangiectasia (Group 2)
    　　　occlusive telangiectasia (Group 3)
    　黄斑円孔
    　黄斑前膜
    　偽黄斑円孔と分層黄斑円孔
    　網膜硝子体牽引症候群
    　ピット黄斑症候群
    　focal choroidal excavation
    　
    III　網膜血管病変
    　糖尿病網膜症
    　　　糖尿病黄斑浮腫
    　高血圧眼底
    　網膜静脈分枝閉塞症
    　網膜中心静脈閉塞症
    　　　乳頭血管炎
    　網膜中心動脈閉塞症
    　網膜細動脈瘤
    　Coats病
    　Leber多発性粟粒血管症
    　Eales病
    　眼虚血症候群
    　放射線網膜症
    　
    IV　網膜周辺部変性症と網膜剝離
    　網膜周辺部変性症
    　網膜剝離
    　
    V　遺伝性網脈絡膜疾患
    　網膜色素変性
    　色素性傍静脈網脈絡膜萎縮症
    　コロイデレミア
    　クリスタリン網膜症
    　黄斑ジストロフィ
    　　　黄斑ジストロフィ　総論
    　　　錐体杆体ジストロフィ
    　　　スタルガルト病
    　　　先天網膜分離症
    　　　卵黄状黄斑ジストロフィ
    　　　後天性卵黄状病巣
    　　　occult macular dystrophy（三宅病）
    　先天停止性夜盲
    　白点状眼底
    　
    VI　ぶどう膜炎
    　3大ぶどう膜炎
    　　　サルコイドーシス
    　　　Behçet病
    　　　原田病
    　網膜色素上皮症
    　　　急性帯状潜在性網膜外層症
    　　　白点症候群
    　　　　　acute posterior multifocal placoid pigment epitheliopathy（APMPPE）
    　　　　　multiple evanscent white dot syndrome（MEWDS）
    　　　　　点状脈絡膜内層症（PIC）
    　　　地図状脈絡膜炎
    　
    VII　網脈絡膜腫瘍
    　毛細血管腫
    　　　網膜毛細血管腫
    　　　傍乳頭血管腫
    　後天性網膜血管腫
    　脈絡膜骨腫
    　脈絡膜母斑
    　脈絡膜血管腫

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[II] 黄斑疾患

P.20 掲載の参考文献
1) Wong CW, et al. : Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res, 53 : 107-139, 2016.
PubMed
1) Oshima Y, et al. : Prevalence of age related maculopathy in a representative Japanese population ; the Hisayama study. Br J Ophthalmol, 85 : 1153-1157, 2001.
 
2) Yasuda M, et al. : Nine-year incidence and risk factors for agerelated macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology, 116 : 2135-2140, 2009. 久山町スタディの続報 (5-year incidence. IOVS, 46 (6) : 1907-1910, 2005.).
 
3) Obata R, et al. : Prevalence and factors associated with age-related macular degeneration in a southwestern island population of Japan : the Kumejima Study. Br J Ophthalmol, 2017
 
4) Zweifel SA, et al. : Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology, 117 : 303-312, 2010.
PubMed
5) Complications of Age-related Macular Degeneration Prevention Trial Research Group : Laser treatment in patients with bilateral large drusen : the complications of age-related macular degeneration prevention trial. Ophthalmology, 113 : 1974-1986, 2006.
 
6) Age-Related Eye Disease Study Research Group : A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss ; AREDS report no. 8. Arch Ophthalmol, 119 : 1417-1436, 2001.
 
P.34 掲載の参考文献
1) 高橋寛二, ほか (厚生労働省網膜脈絡膜・視神経萎縮症調査研究班加齢黄斑変性診断基準作成ワーキンググループ) : 加齢黄斑変性の分類と診断基準. 日眼会誌, 112 : 1076-1084, 2008.
 
2) Gragoudas ES, et al. : Pegaptanib for neovascular age-related macular degeneration. N Engl J Med, 351 : 2805-2816, 2004.
PubMed
3) Brown DM, et al. : Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med, 355 : 1432-1444, 2006.
PubMed
4) Rosenfeld PJ, et al. : Ranibizumab for neovascular age-related macular degeneration. N Engl J Med, 355 : 1419-1431, 2006.
PubMed
5) Heier JS, et al. : Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology, 119 : 2537-2548, 2012.
PubMed
P.44 掲載の参考文献
1) Yannuzzi LA, et al. : Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina, 10 : 1-8, 1990.
PubMed
2) Uyama M, et al. : Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol, 117 : 1035-1042, 1999.
PubMed
3) Uyama M, et al. : Polypoidal choroidal vasculopathy ; natural history. Am J Ophthalmol, 133 : 639-648, 2002.
PubMed
4) 日本ポリープ状脈絡膜血管症研究会 : ポリープ状脈絡膜血管症の診断基準. 日眼会誌, 109 : 417-427, 2005.
 
5) Akaza E, et al. : Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol, 55 : 39-44, 2011.
PubMed
6) Hikichi T, et al. : Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months. Am J Ophthalmol, 150 : 674-682, 2010.
PubMed
7) Koh A, et al. : EVEREST study ; Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina, 32 : 1453-1464, 2012.
 
8) Koh A, et al. : Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy : a randomized clinical trial. JAMA Ophthalmol, 135 : 1206-1213. 2017.
 
P.54 掲載の参考文献
1) Yannuzzi LA, et al. : Retinal angiomatous proliferation in age-related macular degeneration. Retina, 21 : 416-434, 2001.
PubMed
2) Freund KB, et al. : Type 3 neovascularization : the expanded spectrum of retinal angiomatous proliferation. Retina, 8 : 201-211, 2008.
 
P.62 掲載の参考文献
1) Spaide RF : Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol, 147 : 644-652, 2009.
PubMed
2) Cukras C, et al. : Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration : Age-related eye disease study report No. 28. Ophthalmology, 117 : 489-499, 2010.
PubMed
3) Pepple K, Mruthyunjaya P : Retinal pigment epithelial detachments in age-related macular degeneration : classification and therapeutic options. Semin Ophthalmol, 26 : 198-208, 2011.
PubMed
P.66 掲載の参考文献
1) Hochman MA, et al. : Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol, 42 : 195-213, 1997.
PubMed
2) Hassan AS, et al. : Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology, 106 : 1900-1906, 1999.
PubMed
P.70 掲載の参考文献
1) Holz FG, et al. : Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci, 42 : 1051-1056, 2001.
PubMed
2) Rosenfeld PJ, et al. : Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology, 118 : 523-530, 2011.
PubMed
3) 高橋寛二, ほか (厚生労働省網脈絡膜・視神経萎縮症調査研究班) : 萎縮型加齢黄斑変性の診断基準. 日眼会誌, 119 : 616-677, 2015.
 
P.74 掲載の参考文献
1) Gass JD : Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol, 63 : 587-615, 1967.
 
2) Chan WM, et al. : Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy ; one-year results of a randomized controlled trial. Ophthalmology, 115 : 1756-1765, 2008.
PubMed
3) Daruichi A, et al. *Central serous chorioretinopathy : Recent findings and new physiopathology hypothesis Prog Retin Eye Res 48 : 82-118, 2015
PubMed
P.86 掲載の参考文献
1) Morgan IG, et al. : Myopia. Lancet, 379 : 1739-1748, 2012.
PubMed
2) Hayashi K, et al. : Long-term pattern of progression of myopic maculopathy ; a natural history study. Ophthalmology, 117 : 1595-1611, 1611.e1-4, 2010.
 
3) Takano M, Kishi S : Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol, 128 : 472-476, 1999.
PubMed
4) Ohno-Matsui K, et al. : International Photographic Classification and Grading System for Myopic Maculopathy. Am J Ophthalmol, 159 : 877-883, 2015.
PubMed
P.90 掲載の参考文献
1) Wolf S, et al : RADIANCE : a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology, 121 : 682-692, 2014.
PubMed
2) Ikuno Y, et al. : Intravitreal aflibercept injection in patients with myopic choroidal neovascularization : the MYRROR study. Ophthalmology, 122 : 1220-1227, 2015.
PubMed
P.106 掲載の参考文献
1) Gaucher D, et al. : Dome-shaped macula in eyes with myopic posterior staphyloma. Am J Ophthalmol, 145 : 909-914, 2008.
PubMed
2) Imamura Y, et al. : Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol, 151 : 297-302, 2011.
PubMed
P.108 掲載の参考文献
1) Nakanishi H, et al. : Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome. Retina, 28 : 1493-1501, 2008.
PubMed
2) Maruko I, et al. : Morphologic choroidal and scleral changes at the macula in tilted disc syndrome with staphyloma using optical coherence tomography. Invest Ophthalmol Vis Sc, 52 : 8763-8768, 2011.
PubMed
3) Curtin BJ : The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc, 75 : 67-86, 1977.
PubMed
P.112 掲載の参考文献
1) Ho AC, et al. : The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology, 102 : 782-789, 1995.
PubMed
P.118 掲載の参考文献
1) Doyne RW : Choroidal and retinal changes : the result of blows on the eyes. Trans Ophthalmol Soc U K, 9 : 128, 1889.
 
2) Knapp H : On the formation of dark angioid streaks as an unsual metamorphosis of retinal hemorrhage. Arch Ophthalmol, 21 : 289-292, 1892.
 
P.122 掲載の参考文献
1) Gass JD, Blodi BA : Idiopathic juxtafoveolar telangiectasis ; Update of classi_cation and follow-up study. Ophthalmology, 100 : 1536-1546, 1993.
 
2) Yannuzzi LA, et al. : Idiopathic macular telangiectasia. Arch Ophthalmol, 124 : 450-460, 2006.
PubMed
3) Scerri TS, et al. : Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet, 49 : 559-567, 2017.
PubMed
P.128 掲載の参考文献
1) Gass JD : Idiopathic senile macular hole ; Its early stages and pathogenesis. Arch Ophthalmol, 106 : 629-639, 1988.
PubMed
2) Gaudric A, et al. : Macular hole formation ; new data provided by optical coherence tomography. Arch Ophthalmol, 117 : 744-751, 1999.
PubMed
3) Kelly NE, Wendel RT : Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol, 109 : 654-659, 1991.
PubMed
4) Gass JD : Muller cell cone, an overlooked part of the anatomy of the fovea centralis ; hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. Arch Ophthalmol, 117 : 821-823, 1999.
PubMed
5) Kadonosono K, et al. : Staining of the internal limiting membrane in macular hole surgery. Arch Ophthalmol, 118 : 1116-1118, 2000.
PubMed
6) Yamakiri K, et al. : Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology, 114 : 289-296, 2007.
 
P.134 掲載の参考文献
1) Miyazaki M, et al. : Prevalence and risk factors for epiretinal membranes in a Japanese population ; the Hisayama study. Graefes Arch Clin Exp Ophthalmol, 241 : 642-646, 2003.
 
2) Roth AM, Foos RY : Surface wrinkling retinopathy in eyes enucleated at autopsy. Trans Am Acad Ophthalmol Otolaryngol, 75 : 1047-1058, 1971.
PubMed
3) Shimada H, et al. : Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology, 116 : 1370-1376, 2009.
PubMed
4) Tadayoni R, et al. : Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology, 108 : 2279-2283, 2001.
PubMed
P.140 掲載の参考文献
1) Jaffe NS : Vitreous traction at the posterior pole of the fundus due to alterations in the vitreous posterior. Trans Am Acad Ophthalmol Otolaryngol, 71 : 642-652, 1967.
PubMed
2) Smiddy WE, et al. : Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol, 106 : 624-628, 1988.
PubMed
3) Yamada N, Kishi S : Tomographic features and surgical outcomes of vitreomacular traction syndrome. Am J Ophthalmol, 139 : 112-117, 2005.
PubMed
4) Duker JS, et al. : The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. IVTS, international vitreomacular traction study group. Ophthalmology, 120 : 2611-2269, 2013.
 
P.144 掲載の参考文献
1) Wiethe T : Ein fall von angeborener Difformitat der Sehnervenpapille. Arch Augenheilkd, 11 : 14-19, 1882.
 
2) Hirakata A, et al. : Long-term results of vitrectomy without laser treatment for macular detachment associated with an optic disc pit. Ophthalmology, 112 : 1430-1435, 2005.
PubMed
P.148 掲載の参考文献
1) Margolis R, et al. : The Expanded Spectrum of Focal Choroidal Excavation. Arch Ophthalmol, 129 : 1320-1325, 2011.
PubMed

[III] 網膜血管病変

P.156 掲載の参考文献
1) Wilkinson CP, et al. : Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 110 : 1677-1682, 2003.
PubMed
2) http://drcrnet.jaeb.org/
PubMed
3) Gross JG, et al ; Writing Committee for the Diabetic Retinopathy Clinical Research Network : Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy : A Randomized Clinical Trial. JAMA, 314 : 2137-2146, 2015.
PubMed
4) Sivaprasad S, et al. ; CLARITY Study Group : Clinical efficacy of intravitreal a ibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY) : a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet, 389 : 2193-2203, 2017.
 
5) Chun DW, et al. : A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology, 113 : 1706-1712, 2006.
PubMed
6) Diabetic Retinopathy Clinical Research Network, et al. : Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology, 118 : e5-14, 2011.
PubMed
7) Wells JA, et al. ; Diabetic Retinopathy Clinical Research Network : Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med, 372 : 1193-1203, 2015.
 
P.172 掲載の参考文献
1) Scheie HG : Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol, 49 : 117-138, 1953.
PubMed
2) Keith NM, et al. : Some different types of essential hypertension : their course and prognosis. Am J Med Sci, 197 : 332-343, 1939.
 
3) Walsh JB : Hypertensive retinopathy ; description, classification, and prognosis. Ophthalmology, 89 : 1127-1131, 1982.
PubMed
P.176 掲載の参考文献
1) The Branch Vein Occlusion Study Group : Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol, 98 : 271-282, 1984.
 
2) Campochiaro PA, et al. : Ranibizumab for macular edema following branch retinal vein occlusion : six-month primary end point results of a phase III study. Ophthalmology, 117 : A21102-1112.e1, 2010.
 
P.182 掲載の参考文献
1) Fong AC, et al. : Central retinal vein occlusion in young adults (papillophlebitis). Retina, 12 : 3-11, 1992.
PubMed
1) The Central Vein Occlusion Study Group : Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion ; The Central Vein Occlusion Study Group M report. Ophthalmology, 102 : 1425-1433, 1995.
 
2) Fong AC, Schatz H : Central retinal vein occlusion in young adults. Surv Ophthalmol, 37 : 393-417, 1993.
PubMed
2) Brown DM, et al. : Ranibizumab for macular edema following central retinal vein occlusion ; six-month primary end point results of a phase III study. Ophthalmology, 117 : 1124-1133.e1, 2010.
 
3) Brown DM, et al. : Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion : 1-year results from the phase 3 COPERNICUS Study. Am J Ophthalmol, 155 : 429-437, 2012.
PubMed
4) Heier JS, et al. : Ranibizumab for macular edema due to retinal vein occlusions long-term follow-up in the HORIZON Trial. Ophthalmology, 119 : 802-809, 2012.
PubMed
P.190 掲載の参考文献
1) Hayreh SS : Acute retinal arterial occlusive disorders. Prog Retin Eye Res, 30 : 359-394, 2011.
PubMed
P.194 掲載の参考文献
1) Rabb MF : Retinal arterial macroaneurysms. Surv Ophthalmol, 33 : 73-96, 1988.
PubMed
P.200 掲載の参考文献
1) Coats G : Forms of retinal diseases with massive exudation. Roy Lond Ophthalmol Hosp Rep, 17 : 440-525, 1908.
 
2) Shields JA, Shields CL : Review ; coats disease ; the 2001 LuEsther T. Mertz lecture. Retina, 22 : 80-91, 2002.
PubMed
P.202 掲載の参考文献
1) Leber TH : Uber eine durch Vorkommen multipler Miliaraneurysm charakterisierte Form von Retinaldegeneration. Graefes Arch Clin Exp Ophthalmol, 81 : 1-14, 1912.
 
P.204 掲載の参考文献
1) Eales H : Retinal haemorrhages associated with epitaxis and conspitation. Birm Med Rev, 9 : 272-273, 1880.
 
P.206 掲載の参考文献
1) Hedges TR Jr. : Ophthalmoscopic findings in internal carotid artery occlusion. Am J Ophthalmol, 55 : 1007-1012, 1963.
PubMed
2) Mendrinos E, et al. : Ocular ischemic syndrome. Surv Ophthalmol, 55 : 2-34, 2010.
PubMed
P.208 掲載の参考文献
1) Brown GC, et al. : Radiation retinopathy. Ophthalmology, 89 : 1494-1501, 1982.
PubMed

[V] 遺伝性網脈絡膜疾患

P.224 掲載の参考文献
1) Wittes J, et al. : Letter from the DSMC regarding a clinical trial of lutein in patients with retinitis pigmentosa. Arch Ophthalmol, 129 : 675 ; author reply 675-676, 2011.
PubMed
2) Hirakawa H, et al. : Progression of defects in the central 10-degree visual field of patients with retinitis pigmentosa and choroideremia. Am J Ophthalmol, 127 : 436-442, 1999.
PubMed
3) von Ruckmann A, et al. : Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol, 79 : 407-412, 1995.
PubMed
4) Hosono K, et al. : Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One, 7 : e31036, 2012.
PubMed
5) Iwanami M, et al. : High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci, 53 : 1033-1040, 2012.
PubMed
6) Maguire AM, et al. : Safety and efficacy of gene transfer for Leber congenital amaurosis. N Engl J Med, 358 : 2240-2248, 2008.
PubMed
7) Bainbridge J, et al. : Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med, 358 : 2231-2239, 2008.
PubMed
8) https://sph.uth.edu/retnet/
 
9) 厚生労働科学研究費補助金難治性疾患政策研究事業網膜脈絡膜・視神経萎縮症に関する調査研究班, 網膜色素変性診療ガイドライン作成ワーキンググループ : 網膜色素変性診療ガイドライン. 日眼会誌, 120 : 846-861, 2016.
 
P.230 掲載の参考文献
1) Franceschetti A : A curious affection of the fundus oculi ; helicoid peripapillar chorioretinal degeneration. Its relation to pigmentary paravenous chorioretinal degeneration. Doc Ophthalmol, 16 : 81-110, 1962.
PubMed
2) McKay GJ, et al. : Pigmented paravenous chorioretinal atrophy is associated with a mutation within the crumbs homolog 1 (CRB1) gene. Invest Ophthalmol Vis Sci, 46 : 322-328, 2005.
PubMed
P.232 掲載の参考文献
1) Maunther H : Ein fall von choroideremie. Ber Naturw med Ver Innsbruck, 2 : 191-197, 1872.
 
2) Cremers FP, et al. : Cloning of a gene that is rearranged in patients with choroideraemia. Nature, 347 : 674-677, 1990.
PubMed
P.234 掲載の参考文献
1) Bietti GB : Su alcune forme atipiche o rare di degenerazione retinica (degenerazione tappetoretiniche e quadri morbosi similari). Boll Oculist, 16 : 1159-1244, 1937.
 
2) Li A, et al. : Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet, 74 : 817-826, 2004.
PubMed
P.238 掲載の参考文献
1) Kurz-Levin MM, et al. : Clinical variations in assessment of bull's-eye maculopathy. Arch Ophthalmol, 120 : 567-575, 2002.
 
P.246 掲載の参考文献
1) Stargardt K : Uber familiare, progressive Degeneration in der Maculagegend des Auges. Graefes Arch Ophthalmol, 71 : 534-550, 1909.
 
2) Allikmets R, et al. : A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet, 15 : 236-246, 1997.
PubMed
P.250 掲載の参考文献
1) Haas J : Ueber das Zusammenvorkommen von Veranderungen der Retina und Chorioidea. Arch Augenheilk, 37 : 343-348, 1898.
 
2) Sauer CG, et al. : Positional cloning of the gene associated with X linked juvenile retinoschisis. Nat Genet, 17 : 164-170, 1997.
PubMed
P.252 掲載の参考文献
1) Best F : Ueber eine hereditaere Maculaaffektion. Z Augenheilk, 13 : 199-212, 1905.
 
2) Petrukhin K, et al. : Identification of the gene responsible for Best macular dystrophy. Nat Genet, 19 : 241-247, 1998.
 
P.256 掲載の参考文献
1) Gass JDM : Dominantly inherited adult form of vitelliform foveomacular dystrophy. In ; Fine SL, Owens SL, eds. Management of Retinal Vascular and Macular Disorders. Baltimore, MD : Williams & Wilkins, 182-186, 1983.
 
2) Freund KB, et al. : Acquired Vitelliform Lesions : correlation of clinical findings and multiple imaging analyses. Retina, 31 : 13-25, 2011.
PubMed
P.260 掲載の参考文献
1) Miyake Y, et al. : Occult macular dystrophy. Am J Ophtalmol, 122 : 644-653, 1996.
 
2) Akahori M, et al. : Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet, 87 : 424-429, 2010.
PubMed
3) Miyake Y, et al. : Occult macular dystrophy. Jpn J Ophthalmol, 59 : 71-80, 2015.
PubMed
P.264 掲載の参考文献
1) Miyake Y, et al. : Congenital stationary night blindness with negative electroretinogram : a new classification. Arch Ophthalmol, 104 : 1013-1020, 1986.
PubMed
2) 三宅養三 : 新しい疾患概念の確立 ; 先天停止性夜盲の完全型と不全型. 日本眼科學会雜誌, 106 : 737-756, 2002.
 
P.268 掲載の参考文献
1) Krill AE, Folk MR : Retinitis punctata albescens ; a functional evaluation of an unusual case. Am J Ophthalmol, 53 : 450-454, 1962.
 
2) Yamamoto H, et al. : Mutations in the gene encoding 11cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet, 22 : 188-191, 1999.
PubMed

[VI] ぶどう膜炎

P.276 掲載の参考文献
1) Kawagoe T, Mizuki N : Sarcoidosis. Curr Opin Ophthalmol, 22 : 502-507, 2011.
PubMed
2) Umur K, et al. : Different ophthalmologic manifestations of sarcoidosis. Curr Opin Ophthalmol, 23 : 477-484, 2012.
PubMed
P.280 掲載の参考文献
1) Behcet, H. : Uber rezidivierende aphthose, durch ein virus verursachte geschwure am mund, am auge und an der genitalien. Dermatol Wochenschr, 105 : 1152-1157, 1937.
 
2) Mizuki N, et al. : Genome-wide association studies identify IL23RIL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet, 42 : 703-706, 2010.
PubMed
3) Remmers EF, et al. : Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet, 42 : 698-702, 2010.
PubMed
4) Takeuchi M, et al., Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility. Nat Genet.49 ; 438-443, 2017
PubMed
P.284 掲載の参考文献
1) Vogt A : Fruhzeitiges ergrauen der Zilien und Bemerkungen uber den sogenannten plotzlichen Eintritt dieser Veranderung. Klin Mbl Augenheilk, 44 : 228-242, 1906.
 
2) Koyanagi Y : Dysacousia, Alopecia und Poliosis ber schwerer Uveitis nicht traumatischen Ursprunges. Klin Mbl Augenheilked, 82 : 194-211, 1929.
 
3) 原田永之助 : 非化膿性脈絡膜炎ノ臨床知見補遺 (急性瀰漫性脈絡膜炎ニ就テ). 日眼会誌, 30 : 356-378, 1926.
 
4) Bordaberry MF : Vogt-Koyanagi-Harada disease : diagnosis and treatments update. Curr Opin Ophthalmol, 21 : 430-435, 2010.
PubMed
5) Read RW et al. : Revised diagnostic criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol, 131 : 647-652, 2001.
PubMed
P.288 掲載の参考文献
1) Gass JD, et al. : Acute zonal occult outer retinopathy ; a long-term follow-up study. Am J Ophthalmol, 134 : 329-339, 2002.
PubMed
2) Monson DM, Smith JR : Acute zonal occult outer retinopathy. Surv Ophthalmol, 56 : 23-35, 2011.
PubMed
P.292 掲載の参考文献
1) Quillen DA, et al. : The white dot syndromes. Am J Ophthalmol, 137 : 538-550, 2004.
PubMed
2) Gass JDM : Acute posterior multifocal pigment epitheliopathy. Arch Ophthalmol, 80 : 177-185, 1968.
 
3) Amer R, Lois N : Punctate inner choroidopathy. Surv Ophthalmol, 56 : 36-53, 2011.
PubMed
P.298 掲載の参考文献
1) Baarsma GS, Deutman AF : Serpiginous (geographic) choroiditis. Doc Ophthalmol, 40 : 269-285, 1976.
PubMed

[VII] 網脈絡膜腫瘍

P.302 掲載の参考文献
1) Singh AD, et al. : Retinal capillary hemangioma ; a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology, 108 : 1907-1911, 2001.
PubMed
2) Latif F, et al. : Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260 : 1317-1320, 1993.
PubMed
P.312 掲載の参考文献
1) Gass JDM, et al. : Choroidal osteoma. Arch Ophthalmol, 96 : 428-435, 1978.
 
P.314 掲載の参考文献
1) Shields JA, Shields CL : Choroidal nevus. In ; Shields JA, Shields CL, eds. Intraocular Tumors : An Atlas and Textbook. Philadelphia, PA ; Lippincott Williams & Wilkins, 60-67, 2008.
 
2) Shields CL, et al. : Choroidal nevus transformation into melanoma : analysis of 2514 consecutive cases. Arch Ophthalmol, 127 : 981-987, 2009.
PubMed
P.316 掲載の参考文献
1) Shields CL, et al. : Circumscribed choroidal hemangioma ; clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology, 108 : 2237-2248, 2001.
PubMed

書評

最近チェックした商品履歴

Loading...